LeMaitre Vascular Inc
$ 114.81
-2.20%
15 Apr - close price
- Market Cap 2,682,103,000 USD
- Current Price $ 114.81
- High / Low $ 117.42 / 114.09
- Stock P/E 46.58
- Book Value 17.28
- EPS 2.52
- Next Earning Report f
- Dividend Per Share $0.80
- Dividend Yield 0.69 %
- Next Dividend Date -
- ROA 0.07 %
- ROE 0.16 %
- 52 Week High 118.01
- 52 Week Low 77.30
About
LeMaitre Vascular, Inc. designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular diseases worldwide. The company is headquartered in Burlington, Massachusetts.
Analyst Target Price
$111.22
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-25 | 2025-11-06 | 2025-07-30 | 2025-04-30 | 2025-02-25 | 2024-10-31 | 2024-08-01 | 2024-05-02 | 2024-02-27 | 2023-11-01 | 2023-08-01 | 2023-05-02 |
| Reported EPS | 0.68 | 0.62 | 0.6 | 0.48 | 0.49 | 0.49 | 0.52 | 0.44 | 0.38 | 0.33 | 0.36 | 0.27 |
| Estimated EPS | 0.66 | 0.57 | 0.5667 | 0.4978 | 0.49 | 0.44 | 0.47 | 0.39 | 0.36 | 0.3 | 0.32 | 0.25 |
| Surprise | 0.02 | 0.05 | 0.0333 | -0.0178 | 0 | 0.05 | 0.05 | 0.05 | 0.02 | 0.03 | 0.04 | 0.02 |
| Surprise Percentage | 3.0303% | 8.7719% | 5.8761% | -3.5757% | 0% | 11.3636% | 10.6383% | 12.8205% | 5.5556% | 10% | 12.5% | 8% |
Next Quarterly Earnings
| Apr 2026 | |
|---|---|
| Reported Date | f |
| Fiscal Date Ending | o |
| Estimated EPS | r |
| Currency | m |
Previous Dividend Records
| Mar 2026 | Dec 2025 | Sep 2025 | May 2025 | Jan 1970 | Mar 2025 | Dec 2024 | Aug 2024 | May 2024 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-26 | 2025-12-04 | 2025-09-04 | 2025-05-29 | None | 2025-03-27 | 2024-12-05 | 2024-08-29 | 2024-05-30 | 2024-03-28 |
| Amount | $0.25 | $0.2 | $0.2 | $0.2 | $0.2 | $0.2 | $0.16 | $0.16 | $0.16 | $0.16 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: LMAT
2026-04-15 21:26:00
LEMAITRE VASCULAR INC's CEO, George W. LeMaitre, is estimated to have received $3,780,990 in compensation in 2025, marking a 14.43% increase from 2024. The article also covers recent insider trading activity, government contracts won by LMAT, institutional investor movements, and recent analyst price targets for the stock. This information is based on a DEF14A SEC filing from April 14, 2026.
2026-04-15 11:10:19
Zacks Research has upgraded LeMaitre Vascular (NASDAQ:LMAT) to a "Strong-Buy" rating, aligning with other firms that have also raised their ratings and price targets. This upgrade follows LeMaitre Vascular's Q4 financial results, which slightly exceeded expectations with reported EPS of $0.68 and revenue of $64.45 million, a 15.7% increase year-over-year. Despite recent significant insider selling, the company's stock performance shows positive trends, and institutional investors have been adjusting their positions.
2026-04-15 07:10:19
Annex Advisory Services LLC increased its stake in LeMaitre Vascular, Inc. by 6.0% in Q4 2025, now holding 243,709 shares valued at $19.77 million. This comes despite significant insider selling, with CEO George W. Lemaitre and other insiders selling a total of 215,438 shares worth over $23 million. LeMaitre Vascular exceeded Q4 earnings estimates, raised its quarterly dividend, and received a "Moderate Buy" consensus rating from analysts with an average target price of $105.80.
2026-04-14 21:10:19
LeMaitre Vascular, Inc. is scheduled to release its first-quarter 2026 financial results on Tuesday, May 5, 2026, after the market closes. The company will also host a conference call at 5:00 PM EDT on the same day to discuss these results, business highlights, and its outlook. Interested parties can register online for dial-in information or access the audio webcast via playback.
2026-04-14 21:09:51
LeMaitre Vascular, Inc. announced that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after market close. The company will host a conference call at 5:00 PM EDT on the same day to discuss the results, business highlights, and future outlook. Access to the call requires online registration, and an audio webcast will also be available on their investor relations website.
2026-04-14 21:09:50
LeMaitre Vascular (Nasdaq: LMAT) is scheduled to release its first-quarter 2026 financial results on Tuesday, May 5, 2026, after the market close. The company will also host a conference call at 5:00 PM EDT on the same day to discuss the results, business highlights, and company outlook. Investors can register online to access the live call, with an audio webcast and replay available on the company's investor site.
